Algo version: 0.98b
Caplin Point Laboratories is listed at the NSE Exchange
Caplin Point Laboratories [CAPLIPOINT.NS]
NSE Sector: Healthcare Industry:Drug Manufacturers—Specialty & Generic

Is Caplin Point Laboratories stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

Yes, Caplin Point Laboratories pays dividends. Last time was Wednesday 30th of October 2024 where the investors holding the stock on Monday 23rd of September 2024 were paid INR2.5 per share. Over the last 17 times between 2014 and 2024, Caplin Point Laboratories has paid INR39.7 with an average of INR2.34 per share.

Sorry, we do not have any analyst data for this ticker

We cannot find data for Caplin Point Laboratories 10 years ago, but if you had invested on Monday 9th of September 2019 when the price was INR421.10, you would have made a profit of INR1 583.05 per share or 375.93%

Yes, the average daily trading liquidity for Caplin Point Laboratories is INR421 750 thousand. You should therefore be able to get in and out of your positions relatively fast.

Caplin Point Laboratories has no real debt, which is good in periods of high inflation. With a high cash flow to debt ratio of 37.60, the company's ability to pay off the debt is good. Caplin Point Laboratories has a very good net profit margin of 28.04% and should have very high tolerances against inflation.

We have calculated the inflation risk for Caplin Point Laboratories to be low [0 of 1]

US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.